Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Screening for Silent Atrial Fibrillation During Influenza Vaccination

This study has been completed.
Sponsor:
Collaborator:
Boehringer Ingelheim
Information provided by (Responsible Party):
Monika Hollander, MD, PhD, UMC Utrecht
ClinicalTrials.gov Identifier:
NCT02006524
First received: December 4, 2013
Last updated: May 11, 2016
Last verified: May 2016

December 4, 2013
May 11, 2016
October 2013
December 2014   (final data collection date for primary outcome measure)
Newly detected AF [ Time Frame: during influenza vaccination ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT02006524 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Screening for Silent Atrial Fibrillation During Influenza Vaccination
Screening for Silent Atrial Fibrillation During Influenza Vaccination
Silent atrial fibrillation is an important cause of unnecessary strokes. If diagnosed and treated in time with anticoagulants, many disabling strokes can be prevented. In order to improve the diagnosis of atrial fibrillation the MyDiagnostick is developed; a user friendly and easy to use stick that diagnoses atrial fibrillation in one minute. During influenza vaccination, many patients who are also at risk for atrial fibrillation visit the general practice. This offers an ideal opportunity for screening for atrial fibrillation. The study investigates the yield of screening for atrial fibrillation with the MyDiagnostick during influenza vaccination (newly detected atrial fibrillation with corresponding CHA2DS2-Vasc score).
Not Provided
Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Atrial Fibrillation
Device: `MyDiagnostick
Active Comparator: Screening with MyDiagnostick
All patients eligible for influenza vaccination are screened for atrial fibrillation with the MyDiagnostick, an easy to use and patient friendly device.
Intervention: Device: `MyDiagnostick
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
3269
December 2014
December 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Eligible for influenza vaccination

Exclusion Criteria:

  • Not eligible for influenza vaccination
Both
Child, Adult, Senior
Yes
Contact information is only displayed when the study is recruiting subjects
Netherlands
 
NCT02006524
2013-85
Yes
Not Provided
Not Provided
Monika Hollander, MD, PhD, UMC Utrecht
UMC Utrecht
Boehringer Ingelheim
Principal Investigator: Robert Tieleman, MD PhD Martini Ziekenhuis Groningen
Principal Investigator: Monika Hollander, MD PhD Julius Center UMC Utrecht
UMC Utrecht
May 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP